FOXP3 and non-small cell lung carcinoma: Although both major types of NSCLC contributed to an increase in plasma anti-CD25a and anti-FOXP3 IgG levels (Table 3), decreased anti-CD25b IgG levels were observed only in patients with adenocarcinoma (Z = −4.22, P < 0.001).